Current Neuropharmacology
Volume 18, 12 Issues, 2020
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Contents
Current Neuropharmacology, Volume 13 - Number 5
Editorial
Editorial (Thematic Issue: Translational Perspectives in Treatment-Resistant Mood Disorders)
, 13(5): 556 - 557Andre F. Carvalho and Roger S. McIntyre
DOI: 10.2174/1570159X1305151013195022
The Involvement of TNF-α in Cognitive Dysfunction Associated with Major Depressive Disorder: An Opportunity for Domain Specific Treatments
, 13(5): 558 - 576Beatrice Bortolato, Andre F. Carvalho, Joanna K. Soczynska, Giulia I. Perini and Roger S. McIntyre
DOI: 10.2174/1570159X13666150630171433
The Involvement of TNF-α in Cognitive Dysfunction Associated with Major Depressive Disorder: An Opportunity for Domain Specific Treatments
Treatment-resistant Late-life Depression: Challenges and Perspectives
, 13(5): 577 - 591Christian Knochel, Gilberto Alves, Benedikt Friedrichs, Barbara Schneider, Anna Schmidt-Rechau, Sofia Wenzler, Angelina Schneider, David Prvulovic, Andre F. Carvalho and Viola Oertel-Knochel
DOI: 10.2174/1570159X1305151013200032
Treatment-resistant Late-life Depression: Challenges and Perspectives
Pharmacological Approaches for Treatment-resistant Bipolar Disorder
, 13(5): 592 - 604Shi Hui Poon, Kang Sim and Ross J. Baldessarini
DOI: 10.2174/1570159X13666150630171954
Pharmacological Approaches for Treatment-resistant Bipolar Disorder
From Randomized Controlled Trials of Antidepressant Drugs to the Meta-Analytic Synthesis of Evidence: Methodological Aspects Lead to Discrepant Findings
, 13(5): 605 - 615Konstantinos N. Fountoulakis, Roger S. McIntyre and Andre F. Carvalho
DOI: 10.2174/1570159X13666150630174343
From Randomized Controlled Trials of Antidepressant Drugs to the Meta-Analytic Synthesis of Evidence: Methodological Aspects Lead to Discrepant Findings
Challenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved Therapeutics
, 13(5): 616 - 635Rafael T. de Sousa, Marcus V. Zanetti, Andre R. Brunoni and Rodrigo Machado-Vieira
DOI: 10.2174/1570159X13666150630173522
Challenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved Therapeutics
Beyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive Review
, 13(5): 636 - 655Joshua D. Rosenblat, Roger S. McIntyre, Gilberto S. Alves, Konstantinos N. Fountoulakis and Andre F. Carvalho
DOI: 10.2174/1570159X13666150630175044
Beyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive Review
Future Directions for Pharmacotherapies for Treatment-resistant Bipolar Disorder
, 13(5): 656 - 662Seetal Dodd, Brisa S. Fernandes and Olivia M. Dean
DOI: 10.2174/1570159X13666150630175841
Future Directions for Pharmacotherapies for Treatment-resistant Bipolar Disorder
Omega 3 Fatty Acids: Novel Neurotherapeutic Targets for Cognitive Dysfunction in Mood Disorders and Schizophrenia?
, 13(5): 663 - 680Christian Knochel, Martin Voss, Florian Gruter, Gilberto S. Alves, Silke Matura, Beate Sepanski, Michael Stablein, Sofia Wenzler, David Prvulovic, Andre F. Carvalho and Viola Oertel-Knochel
DOI: 10.2174/1570159X13666150630173047
Omega 3 Fatty Acids: Novel Neurotherapeutic Targets for Cognitive Dysfunction in Mood Disorders and Schizophrenia?
The Incidence of Akathisia in the Treatment of Schizophrenia with Aripiprazole, Asenapine and Lurasidone: A Meta-Analysis
, 13(5): 681 - 691Jennifer E. Thomas, Joshua Caballero and Catherine A. Harrington
DOI: 10.2174/1570159X13666150115220221
The Incidence of Akathisia in the Treatment of Schizophrenia with Aripiprazole, Asenapine and Lurasidone: A Meta-Analysis
The Management and Outcomes of Pharmacological Treatments for Tinnitus
, 13(5): 692 - 700Devon Beebe Palumbo, Kathleen Joos, Dirk De Ridder and Sven Vanneste
DOI: 10.2174/1570159X13666150415002743
Myalgic Encephalomyelitis: Symptoms and Biomarkers
, 13(5): 701 - 734Leonard A. Jason, Marcie L. Zinn and Mark A. Zinn
DOI: 10.2174/1570159X13666150928105725
Myalgic Encephalomyelitis: Symptoms and Biomarkers
Editor-in-Chief
F. Nicoletti
University Rome"da Sapienza"
Rome
(Italy)
University Rome"da Sapienza"
Rome
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Neuropharmacology was introduced in 2003 and Dr. Ferdinando Nicoletti is the New Editor-in-Chief of the journal, appointed in 2019.
Scopus CiteScore Metrics: 4.72
New eBook
 |
Neurobiology of Mood DisordersYou can view the contents of this eBook [here] or purchase it [here]. |
Advertisement
Webmaster Contact: info@benthamscience.net